Literature DB >> 2955413

Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.

J E Morin, M D Lubeck, J E Barton, A J Conley, A R Davis, P P Hung.   

Abstract

Recombinant adenoviruses carrying the hepatitis B virus surface antigen coding sequence in the adenovirus E3 region were constructed using DNA from either adenovirus type 5 or an adenovirus type 5 E3-region deletion mutant. Both of these recombinant adenoviruses replicated as efficiently as wild-type adenovirus in all human cells tested, including the human diploid cell strain WI-38. This indicates that insertion of the hepatitis B virus surface antigen gene into the E3 region does not significantly affect viral replication. Human cells infected with these recombinant adenoviruses secreted immunoreactive hepatitis B virus surface antigen. Since a practical small animal model for human adenoviruses was lacking, a hamster model was developed to evaluate the immunogenic potential of these recombinant adenoviruses. Upon intranasal inoculation, both wild-type adenovirus and the adenovirus E3-region deletion mutant replicated in the lungs of these animals and induced an antibody response against adenovirus. Hamsters similarly immunized with the live recombinant adenoviruses produced antibody against both adenovirus and hepatitis B virus surface antigen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955413      PMCID: PMC305143          DOI: 10.1073/pnas.84.13.4626

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  IMMUNIZATION WITH TYPES 4 AND 7 ADENOVIRUS BY SELECTIVE INFECTION OF THE INTESTINAL TRACT.

Authors:  R B COUCH; R M CHANOCK; T R CATE; D J LANG; V KNIGHT; R J HUEBNER
Journal:  Am Rev Respir Dis       Date:  1963-09

2.  The serial cultivation of human diploid cell strains.

Authors:  L HAYFLICK; P S MOORHEAD
Journal:  Exp Cell Res       Date:  1961-12       Impact factor: 3.905

3.  Adenovirus transcription. II. RNA sequences complementary to simian virus 40 and adenovirus 2DNA in AD2+ND1- and AD2+ND3-infected cells.

Authors:  S J Flint; Y Wewerka-Lutz; A S Levine; J Sambrook; P A Sharp
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

4.  Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance.

Authors:  M Andersson; S Pääbo; T Nilsson; P A Peterson
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

5.  Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants.

Authors:  B M Bhat; W S Wold
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

Review 6.  Regulation of adenovirus mRNA formation.

Authors:  S J Flint
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

7.  Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome.

Authors:  T J Kelly; A M Lewis
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

8.  Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.

Authors:  F H Top; E L Buescher; W H Bancroft; P K Russell
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

9.  In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses.

Authors:  A Ballay; M Levrero; M A Buendia; P Tiollais; M Perricaudet
Journal:  EMBO J       Date:  1985-12-30       Impact factor: 11.598

Review 10.  Regulation of protein synthesis in virus-infected animal cells.

Authors:  M Kozak
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

View more
  30 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

2.  Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinant.

Authors:  M Gorziglia; A Z Kapikian
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen.

Authors:  X S He; H S Chen; K Chu; M Rivkina; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Homologous recombination in E3 genes of human adenovirus species D.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

5.  Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes.

Authors:  M R Castrucci; S Hou; P C Doherty; Y Kawaoka
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Generation of antiserum to specific epitopes.

Authors:  D C Marchion; D S Manning; W M Shafer; R C Judd
Journal:  Mol Biotechnol       Date:  1996-12       Impact factor: 2.695

7.  Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.

Authors:  M D Lubeck; A R Davis; M Chengalvala; R J Natuk; J E Morin; K Molnar-Kimber; B B Mason; B M Bhat; S Mizutani; P P Hung
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Distinctive properties of the hepatitis B virus envelope proteins.

Authors:  K L Molnar-Kimber; V Jarocki-Witek; S K Dheer; S K Vernon; A J Conley; A R Davis; P P Hung
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

9.  Recombinant adenovirus vectors expressing interleukin-5 and -6 specifically enhance mucosal immunoglobulin A responses in the lung.

Authors:  T A Braciak; W S Gallichan; F L Graham; C D Richards; A J Ramsay; K L Rosenthal; J Gauldie
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

10.  Induction of mucosal immunity in cotton rats to haemagglutinin-esterase glycoprotein of bovine coronavirus by recombinant adenovirus.

Authors:  M E Baca-Estrada; X Liang; L A Babiuk; D Yoo
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.